Development of a Recovery Oriented Treatment for Post-Acute Suicidal Episode (PASE) Veterans

NARecruitingINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

February 22, 2022

Primary Completion Date

November 25, 2025

Study Completion Date

April 25, 2026

Conditions
Suicide
Interventions
BEHAVIORAL

Continuous Identity Cognitive Therapy (CI-CT)

CI-CT was developed as a manualized treatment integrating components of CBT and Acceptance and Commitment Therapy (ACT) with self-continuity and future-self related interventions to help Veterans develop a better present-to-the-future life story as a framework for increasing hopefulness, a sense of life meaning, empowerment, and an ability to attain future self-goals. The recovery oriented CI-CT for post acute suicidal episode Veterans includes eight components: 1) constructing a CI narrative, 2) mindfulness training, 3) life values identification, 4) developing a self-growth perspective, 5) identifying possible future selves - timelines, 6) connecting with the desired future self, 7) CI as context for current problems, and 8) moving toward the future self.

BEHAVIORAL

General Health Education

General Health Education a structured manualized group health education intervention previously developed by VISN 2 MIRECC investigators as a control condition for group psychotherapy RCTs. It has 12 1.5-hour weekly group sessions focusing on health and wellness topics such as Sleep, Physical Activity, Impact of Stress, Relaxation Techniques, Substance Use, Nutrition, Managing Daily Activities, Medication Benefits and Side Effects. GHE was chosen for the AC because it aligns in many respects with CI-CT (e.g., group format, length of sessions, similar expectations) while diverging in specific topics and skills targeted allowing for control of common factors like attention without causing confounding due to overlap in concepts

Trial Locations (1)

10468-3904

RECRUITING

James J. Peters VA Medical Center, Bronx, NY, The Bronx

All Listed Sponsors
lead

VA Office of Research and Development

FED